Our analysis revealed that 10 tumors, namely BLCA, GBM, HNSC, LUAD, LUSC, MESO, PAAD, READ, SKCM, and STAD, experienced a positive correlation between CDKN2A CNA and the expression of CCL4 (Figure 9). This evidence concerns the gene CDKN2A and glioblastoma.